Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Amortization of Deferred Charges (2016 - 2017)

Historic Amortization of Deferred Charges for Cross Country Healthcare (CCRN) over the last 5 years, with Q2 2017 value amounting to $75000.0.

  • Cross Country Healthcare's Amortization of Deferred Charges fell 8263.89% to $75000.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $1.3 million, marking a year-over-year decrease of 3223.54%. This contributed to the annual value of $461000.0 for FY2019, which is 290.18% up from last year.
  • As of Q2 2017, Cross Country Healthcare's Amortization of Deferred Charges stood at $75000.0, which was down 8263.89% from $354000.0 recorded in Q1 2017.
  • Over the past 5 years, Cross Country Healthcare's Amortization of Deferred Charges peaked at $481000.0 during Q3 2014, and registered a low of $52000.0 during Q2 2014.
  • Over the past 5 years, Cross Country Healthcare's median Amortization of Deferred Charges value was $413000.0 (recorded in 2016), while the average stood at $296666.7.
  • Per our database at Business Quant, Cross Country Healthcare's Amortization of Deferred Charges skyrocketed by 80384.62% in 2015 and then tumbled by 8263.89% in 2017.
  • Over the past 5 years, Cross Country Healthcare's Amortization of Deferred Charges (Quarter) stood at $57000.0 in 2013, then soared by 731.58% to $474000.0 in 2014, then grew by 0.21% to $475000.0 in 2015, then fell by 13.05% to $413000.0 in 2016, then plummeted by 81.84% to $75000.0 in 2017.
  • Its last three reported values are $75000.0 in Q2 2017, $354000.0 for Q1 2017, and $413000.0 during Q4 2016.